Functional characterization of cancer-associated Gab1 mutations

Oncogene

Volumn 32, Issue 21, 2013, Pages 2696-2702

  Ortiz Padilla, C ^a   Gallego Ortega, D ^a   Browne, B C ^a   Hochgrafe F ^a   Caldon, C E ^a   Lyons, R J ^a   Croucher, D R ^a   Rickwood, D ^a   Ormandy, C J ^a,c   Brummer, T ^b   Daly, R J ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

breast cancer; mammary; protein phosphorylation; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GRB2 ASSOCIATED BINDER 1 PROTEIN; MEMBRANE PROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE ASSOCIATION; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METASTASIS; MUTATIONAL ANALYSIS; NEGATIVE FEEDBACK; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SUBSTITUTION; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MUTATION, MISSENSE; NEOPLASM PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84878256602     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.271     Document Type: Article

References (42)

1. Wohrle FU, Daly RJ, Brummer T. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal 2009; 7: 22.
2. Lock LS, Frigault MM, Saucier C, Park M. Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. J Biol Chem 2003; 278: 30083-30090.
3. Lock LS, Royal I, Naujokas MA, Park M. Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-depen-dent and-independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem 2000; 275: 31536-31545.
4. Rodrigues GA, Falasca M, Zhang Z, Ong SH, Schlessinger J. A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol Cell Biol 2000; 20: 1448-1459.
5. Maroun CR, Holgado-Madruga M, Royal I, Naujokas MA, Fournier TM, Wong AJ et al. The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 1999; 19: 1784-1799.
6. Abella JV, Vaillancourt R, Frigault MM, Ponzo MG, Zuo D, Sangwan V et al. The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck. J Cell Sci 2010; 123: 1306-1319.
7. Mood K. Saucier C, Bong YS, Lee HS, Park M, Daar IO. Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor. Mol Biol Cell 2006; 17: 3717-3728.
8. Laramee M, Chabot C, Cloutier M, Stenne R, Holgado-Madruga M, Wong AJ et al. The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation. J Biol Chem 2007; 282: 7758-7769.
9. Maroun CR, Naujokas MA, Holgado-Madruga M, Wong AJ, Park M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signalregulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol 2000; 20: 8513-8525.
10. Eulenfeld R, Schaper F. A new mechanism for the regulation of Gab1 recruitment to the plasma membrane. J Cell Sci 2009; 122: 55-64.
11. Yu CF, Roshan B, Liu ZX, Cantley LG. ERK regulates the hepatocyte growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 2001; 276: 32552-32558.
12. Gual P, Giordano S, Anguissola S, Parker PJ, Comoglio PM. Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling. Oncogene 2001; 20: 156-166.
13. Lynch DK, Daly RJ. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J 2002; 21: 72-82.
14. Brummer T, Larance M, Herrera Abreu MT, Lyons RJ, Timpson P, Emmerich CH et al. Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. EMBO J 2008; 27: 2305-2316.
15. Arnaud M, Crouin C, Deon C, Loyaux D, Bertoglio J. Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation. J Immunol 2004; 173: 3962-3971.
16. Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N et al. A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 2006; 12: 114-121.
17. Bocanegra M, Bergamaschi A, Kim YH, Miller MA, Rajput AB, Kao J et al. Focal amplification and oncogene dependency of GAB2 in breast cancer. Oncogene 2010; 29: 774-779.
18. Brown LA, Kalloger SE, Miller MA, Shih Ie M, McKinney SE, Santos JL et al. Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer 2008; 47: 481-489.
19. Chernoff KA, Bordone L, Horst B, Simon K, Twadell W, Lee K et al. GAB2 amplifications refine molecular classification of melanoma. Clin Cancer Res 2009; 15: 4288-4291.
20. Daly RJ, Gu H, Parmar J, Malaney S, Lyons RJ, Kairouz R et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 2002; 21: 5175-5181.
21. Fleuren ED, O'Toole S, Millar EK, McNeil C, Lopez-Knowles E, Boulghourjian A et al. Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development. Int J Cancer 2010; 127: 1486-1492.
22. Horst B, Gruvberger-Saal SK, Hopkins BD, Bordone L, Yang Y, Chernoff KA et al. Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol 2009; 174: 1524-1533.
23. Lee SH, Jeong EG, Nam SW, Lee JY, Yoo NJ. Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology 2007; 39: 326-329.
24. Zatkova A, Schoch C, Speleman F, Poppe B, Mannhalter C, Fonatsch C et al. GAB2 is a novel target of 11q amplification in AML/MDS. Genes Chromosomes Cancer 2006; 45: 798-807.
25. Juric D, Lacayo NJ, Ramsey MC, Racevskis J, Wiernik PH, Rowe JM et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and-negative adult acute lymphoblastic leukemias. J Clin Oncol 2007; 25: 1341-1349.
26. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G et al. Medullo-blastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol 2011; 121: 381-396.
27. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314: 268-274.
28. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990; 50: 6075-6086.
29. Drasin DJ, Robin TP, Ford HL. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 2011; 13: 226.
30. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268.
31. Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J Cell Biol 2004; 165: 263-273.
32. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2 but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 2001; 3: 785-792.
33. Brummer T, Schramek D, Hayes VM, Bennett HL, Caldon CE, Musgrove EA et al. Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. J Biol Chem 2006; 281: 626-637.
34. Reginato MJ, Mills KR, Becker EB, Lynch DK, Bonni A, Muthuswamy SK et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol 2005; 25: 4591-4601.
35. Khwaja A, Lehmann K, Marte BM, Downward J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J Biol Chem 1998; 273: 18793-18801.
36. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 1988; 7: 2089-2095.
37. Xian W, Schwertfeger KL, Vargo-Gogola T, Rosen JM. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol 2005; 171: 663-673.
38. Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 2007; 448: 439-444.
39. Landgraf KE, Pilling C, Falke JJ. Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain. Biochemistry 2008; 47: 12260-12269.
40. Ferguson KM, Kavran JM, Sankaran VG, Fournier E, Isakoff SJ, Skolnik EY et al. Structural basis for discrimination of 3-phosphoinositides by pleckstrin homology domains. Mol Cell 2000; 6: 373-384.
41. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 2006; 16: 162-172.
42. Janes PW, Daly RJ, deFazio A, Sutherland RL. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994; 9: 3601-3608.